Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Bio-protocol

Mouse Intratongue Injection With Cancer Cells—An Orthotopic Model for Head and Neck Squamous Cell Carcinoma

5 affiliations
  1. 1Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland
  2. 2Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland
  3. 3Turku Collegium for Science, Medicine and Technology (TCSMT), Turku, Finland
  4. 4InFLAMES Research Flagship Center, University of Turku and Åbo Akademi University, Turku, Finland
  5. 5Foundation for the Finnish Cancer Institute, Tukholmankatu 8, FI-00014 Helsinki, Finland

Abstract

Syngeneic and orthotopic injection of cancer cells in mice is a gold standard model in pre-clinical cancer research. Herein, we detail a protocol of orthotopic intratongue injection as a model for upper respiratory tract cancer studies. This model recapitulates tumor growth and invasion in an orthotopic site, the oral cavity mucosa. It can be experimentally designed in a syngeneic context or used to study patient-derived cells in immunocompromised animals. Procedurally, mice are anesthetized and injected with a small volume of cancer cell suspension near the lateral border of the tongue, right under the mucous membrane. Post-injection, animal welfare is carefully attended to by appropriate analgesia, while providing soft food for the duration of the experiment to ensure the ability of the mice to eat ad libitum. Tongues and potential metastatic organs are dissected and can be sampled and analyzed using relevant state-of-the-art methods, including -omics and imaging approaches. We describe a broad range of distinct tumor profiling and analysis methods applicable to this model. These include physical measurements of elasticity with atomic force microscopy on fresh tissue, hematoxylin-eosin staining and standard immunohistochemistry, and confocal microscopy applied to paraffin-embedded tongue sections. This model is orthotopic, accessible without surgery, easy to monitor, and rapid to perform.

Key features

• Orthotopic and clinically relevant head and neck squamous cell carcinoma (HNSCC) model.

• Rapid, reproducible, and minimally invasive procedure.

• Compatible with multimodal downstream analyses.

• Versatile platform for preclinical studies.

Related

  1. GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: Different pattern of squamous cell carcinoma and adenocarcinoma
    Ahmed Abbas
    World Journal of GastroenterologyPeer-reviewedCC BY-NCFull text99 citedMolecular biology & gene regulationHAL
  2. Advances in Treatment of Refractory Advanced and Recurrent Cervical Adenocarcinoma: Molecular Heterogeneity and Differences from Squamous Cell Carcinoma
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  3. Inhibitory Mechanism of Bee Venom Against A431 Cutaneous Squamous Cell Carcinoma Cells Based on Label-Free Proteomics and Untargeted Metabolomics
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  4. Saliva-based genomic signatures for early detection of oral squamous cell carcinoma: the state and perspectives of translation
    Hiren Hansraj Patadiya, Satya Upadhyayula, Vrunda T. Adeshara
    Frontiers in geneticsPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  5. Multiomics analysis reveals the enhancer landscapes and 3D chromatin architecture in esophageal squamous cell carcinoma
    Haoqiang Sun, Yongjie Wang, Wenwen Xu +9
    Communications BiologyPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
BibTeX
@article{follain2026mouse,
  title = {{Mouse Intratongue Injection With Cancer Cells—An Orthotopic Model for Head and Neck Squamous Cell Carcinoma}},
  author = {Gautier Follain and Jasmin Kaivola and Omkar Joshi and Mathilde Mathieu and Johanna Ivaska},
  journal = {Bio-protocol},
  year = {2026},
  month = nov,
  doi = {10.21769/bioprotoc.5861},
  url = {https://doi.org/10.21769/bioprotoc.5861},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Mouse Intratongue Injection With Cancer Cells—An Orthotopic Model for Head and Neck Squamous Cell Carcinoma
AU  - Gautier Follain
AU  - Jasmin Kaivola
AU  - Omkar Joshi
AU  - Mathilde Mathieu
AU  - Johanna Ivaska
PY  - 2026
DA  - 2026/11/05
JO  - Bio-protocol
DO  - 10.21769/bioprotoc.5861
UR  - https://doi.org/10.21769/bioprotoc.5861
AB  - Syngeneic and orthotopic injection of cancer cells in mice is a gold standard model in pre-clinical cancer research. Herein, we detail a protocol of orthotopic intratongue injection as a model for upper respiratory tract cancer studies. This model recapitulates tumor growth and invasion in an orthotopic site, the oral cavity mucosa. It can be experimentally designed in a syngeneic context or used to study patient-derived cells in immunocompromised animals. Procedurally, mice are anesthetized and injected with a small volume of cancer cell suspension near the lateral border of the tongue, right under the mucous membrane. Post-injection, animal welfare is carefully attended to by appropriate analgesia, while providing soft food for the duration of the experiment to ensure the ability of the mice to eat ad libitum. Tongues and potential metastatic organs are dissected and can be sampled and analyzed using relevant state-of-the-art methods, including -omics and imaging approaches. We describe a broad range of distinct tumor profiling and analysis methods applicable to this model. These include physical measurements of elasticity with atomic force microscopy on fresh tissue, hematoxylin-eosin staining and standard immunohistochemistry, and confocal microscopy applied to paraffin-embedded tongue sections. This model is orthotopic, accessible without surgery, easy to monitor, and rapid to perform.  Key features  • Orthotopic and clinically relevant head and neck squamous cell carcinoma (HNSCC) model.  • Rapid, reproducible, and minimally invasive procedure.  • Compatible with multimodal downstream analyses.  • Versatile platform for preclinical studies.
SN  - 2331-8325
ER  -